JESSICA BRZOZOWSKI: Open Payments
NPI 1982941266 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,102 in 83 payments from 15 companies in 2025. Trend: 2023 $2,402 · 2024 $1,962 · 2025 $2,102
Food & beverage: $2,102
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $376 |
| ABBVIE INC. | 13 | $330 |
| Otsuka America Pharmaceutical, Inc. | 14 | $283 |
| Alkermes, Inc. | 16 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $198 |
| Supernus Pharmaceuticals, Inc. | 6 | $192 |
| Lundbeck LLC | 4 | $99 |
| Vertical Pharmaceuticals, LLC | 5 | $91 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
Products named: SPRAVATO, REXULTI, VRAYLAR, ARISTADA, CAPLYTA, Qelbree, Relexxii, Auvelity.
Industry payments across TX — which companies pay providers there.
